retatrutide approval status october 2025 Compounded Semaglutide vs Wegovy GLP-1 Weight Loss- Compounded Semaglutide

Suzuki K, Hatzikotoulas K, Southam L, et al

This study represents a critical step in understanding the complex biology of neuroendocrine tumors and the unintended effects of medications on rare cancers

Tirzepatide activates both the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), both class B GPCRs, though with differential potency

What else you should know Foundayo is approved for people with weight-related comorbid conditions

Tirzepatide or Semaglutide One self-administered injection per week Extensive published clinical trial data Dosing titrated gradually with your nurse Foundayo A pill taken once a day, no injections Same manufacturer as Zepbound A fit for patients who prefer to avoid needles Not sure which fits

Our program combines evidence-based GLP-1 care with personalized rheumatology and lifestyle medicine, delivered compassionately through telemedicine